Target intelligence / Profile preview

Reactive oxygen species generation and redox homeostasis (ROS/Redox)

Target
ROS/Redox
Molecular classification
Enzyme, Transcription factor, Other
01

Overview

Reactive oxygen species (ROS) generation and redox homeostasis refer to the complex biological system that maintains the balance between the production of reactive oxygen species and their neutralization by antioxidant defenses [1.1.1, 1.3.1]. ROS, such as superoxide and hydrogen peroxide, are primarily generated by the mitochondrial electron transport chain and enzymes like NADPH oxidases (NOX) [1.1.1, 1.2.5]. While physiological levels of ROS are essential for signal transduction, cell proliferation, and immune responses, an imbalance leading to excessive ROS—termed oxidative stress—causes damage to DNA, proteins, and lipids [1.2.1, 1.3.4]. This system is a critical therapeutic focus in cancer, where pro-oxidant drugs like doxorubicin and cisplatin are used to overwhelm the antioxidant capacity of tumor cells and induce apoptosis or ferroptosis [1.1.1, 1.5.2]. Conversely, in neurodegenerative and cardiovascular diseases, the goal is often to restore redox balance using antioxidants or Nrf2 activators to prevent oxidative damage [1.3.3, 1.4.2]. However, the dual role of ROS as both signaling molecules and toxic agents presents a significant challenge, as non-specific modulation can interfere with vital cellular processes [1.4.1, 1.5.1].

Other names
Oxidative stressRedox signalingRedox balanceROS metabolismCellular redox state
02

Mechanism of action

Drugs targeting this system act by either inducing oxidative stress to trigger cell death (pro-oxidants) or by enhancing antioxidant capacity and scavenging free radicals to prevent tissue damage (antioxidants) [1.1.1, 1.3.2].

03

Biological functions

Signal transductionApoptosisCell proliferationCell deathImmune responseMetabolism
04

Disease associations

CancerInflammationNeurodegenerative diseaseCardiovascular diseaseDiabetes
05

Safety considerations

Disruption of physiological ROS signaling [1.4.1]Off-target oxidative damage to healthy tissues [1.5.1]Development of drug resistance through redox adaptation [1.4.2]Lack of specificity in global antioxidant therapies [1.3.1]
06

Interacting drugs

Doxorubicin

9 more in the full profile.

07

Biomarkers

8-hydroxydeoxyguanosine (8-OHdG)Malondialdehyde (MDA)4-hydroxynonenal (4-HNE)Protein carbonylsGSH/GSSG ratioSuperoxide dismutase (SOD)

Beyond the preview

Go deeper on Reactive oxygen species generation and redox homeostasis (ROS/Redox).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Reactive oxygen species generation and redox homeostasis (ROS/Redox).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call